Mohammad Abdollahi (MA) acquired a PharmD in 1988 from the University of Tehran and then finished a PhD in Pharmacology and Toxicology in 1994 from the Tehran University of Medical Sciences (TUMS).

He gained a postdoctoral fellowship in Mechanistic and Clinical Toxic pharmacology at the University of Toronto in 2001. MA has obtained the honor of full professorship of TUMS since the second half of 2002. 

MA currently heads the Institute of Pharmaceutical Sciences (TIPS), one of the prominent centers in the region.

MA has been listed among top scientists of the OIC Member States. 

According to Scopus, the current H-index and total citations of MA are 80 and more than 26000, respectively. 

Since 2004, MA has received recognition by the ESI as a top 1% scientist in the field of "Pharmacology and Toxicology", "Clinical Medicine" and "Agricultural Sciences".

MA is the Editor-in-Chief DARU, a prestigious Pharmaceutical Journal published by Springer Nature. 

He is an individual member of many academic societies such as EUROTOX (Europe), SOT (USA), and a temporary adviser of WHO in the Guideline Developing Group for Prevention of Lead Poisoning.

MA has cooperated with OPCW as a Scientific Advisory Board member and COPE as a Council Member for two terms of office. Besides more than 30 prestigious awards, MA is the laureate of the IAS-COMSTECH Prize in 2005 in Pharmacology & Toxicology. 

He has been elected as the IAS Fellow since 2007. The main research interests of MA are Mechanistic and Environmental Toxics pharmacology.

MA's contributions to this field are attested by an extensive array of citations in papers and books. MA has uncovered the critical mechanistic connections between the toxicity of chemicals and the etiology of human diseases.